Post

New research · Ophthalmology
Ophthalmology and therapy · 2d
Cohort studyOphthalmology and therapy · 2026

Short-Term Intraocular Pressure Changes After Intravitreal Aflibercept 8 mg via Prefilled Syringe.

Arianna Peyla, Matteo Bonanata, Martina Pache … Giulio Volpe
Read paper
OphthalmologyCohort study

Aflibercept 8 mg prefilled syringe injections were linked to a brief, sharp eye-pressure spike.

Short-Term Intraocular Pressure Changes After Intravitreal Aflibercept 8 mg via Prefilled Syringe.

Arianna Peyla … Giulio Volpe
Ophthalmology and therapy · 2026
Background

Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy is a standard treatment for neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (diabetic macular oedema).

Purpose

The aim of this study was to assess short-term IOP changes after intravitreal aflibercept 8 mg administered via PFS and to compare these results with historical cohorts receiving aflibercept 8 mg via standard syringe and aflibercept 2 mg via PFS.

Methods

With glaucoma or ocular hypertension were excluded.

Results

Eye pressure jumped from ~14 to about 51 mmHg 30 seconds after injection, then fell.

Baseline
13.92mmHg
30 s
51.29mmHg
5 min
31.32mmHg
15 min
20.25mmHg
More results

Baseline IOP was similar across the three groups (p = 0.54).

No statistically significant between-group differences were detected at any timepoint (all p ≥ 0.18).

“
Conclusion · 1 of 2

Intravitreal aflibercept 8 mg administered via PFS was associated with a transient rise in IOP immediately after injection, which resolved within 15 min and was similar to that observed with aflibercept 2 mg via PFS and aflibercept 8 mg via standard syringe.

Conclusion · 2 of 2

These findings contribute to the characterization of the short-term IOP response associated with aflibercept 8 mg PFS administration and may help inform routine clinical practice.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment